Abeona Therapeutics
(ABEO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-1999 | 03-1999 | 12-1998 | 09-1998 | 06-1998 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,680 | -790 | -3,390 | -2,630 | -1,820 |
| Depreciation Amortization | 90 | 40 | 210 | 160 | 130 |
| Other Working Capital | 20 | 40 | -90 | -100 | -90 |
| Other Operating Activity | 390 | 140 | 40 | 10 | 0 |
| Operating Cash Flow | $-1,180 | $-570 | $-3,230 | $-2,560 | $-1,780 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | 0 | 5 | -4 | -3 |
| Net Acquisitions | 0 | 0 | -100 | -50 | -50 |
| Other Investing Activity | 0 | 0 | 5 | 4 | 3 |
| Investing Cash Flow | $0 | $0 | $-90 | $-50 | $-50 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -40 | -20 | 4,380 | 4,400 | 3,570 |
| Financing Cash Flow | $-40 | $-20 | $4,380 | $4,400 | $3,570 |
| Beginning Cash Position | 1,480 | 1,480 | 430 | 430 | 430 |
| End Cash Position | 250 | 880 | 1,480 | 2,230 | 2,170 |
| Net Cash Flow | $-1,220 | $-600 | $1,040 | $1,790 | $1,730 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,180 | -570 | -3,230 | -2,560 | -1,780 |
| Free Cash Flow | -1,180 | -570 | -3,230 | -2,560 | -1,780 |